Ernest Pharmaceuticals
PrivateLast Round
Grant
Mar 7, 2024
Total Funding Raised
$1.55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ernest Pharmaceuticals operates in Healthcare & Life Sciences and is based in Hadley, Massachusetts. Its latest recorded funding round was a Grant round in March 2024.
Ernest Pharmaceuticals is a biotechnology company that develops bacterial therapeutics for the treatment of solid tumors through intracellular macromolecule delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ernest Pharmaceuticals Comparables
Compare Ernest Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SiVEC Biotechnologies | 84% | |
| Baccine Ltd. | 84% | |
| Laguna Bio | 83% |
For institutional investors. Book with your work email.
Ernest Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 7, 2024 | ||||
| Accelerator | Mar 16, 2022 | ||||
| Grant | Jan 15, 2021 | ||||
| Grant | Sep 15, 2020 | ||||
| Grant | Sep 13, 2019 | ||||
Grant | Sep 9, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ernest Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| The Termeer Institute | Accelerator |
| Massachusetts Life Sciences Center | Grant |
| National Institutes of Health (NIH) | Grant |
| Lever | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 2295% MoM, reaching 2.1K.
- Mar 1, 2026
Monthly visitors grew 641% MoM, from 200 to 1.5K.
For institutional investors. Book with your work email.
Ernest Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ernest Pharmaceuticals's valuation, stock price, and market status.
Is Ernest Pharmaceuticals a public or private company?
Ernest Pharmaceuticals is a private company.
What is the current stock price of Ernest Pharmaceuticals?
Ernest Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Ernest Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ernest Pharmaceuticals worth (valuation)?
Valuation information for Ernest Pharmaceuticals is not publicly available.
Can I buy Ernest Pharmaceuticals stock?
Ernest Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ernest Pharmaceuticals's last funding round?
Ernest Pharmaceuticals's most recent funding round was Grant on March 7, 2024.
Who are the main investors in Ernest Pharmaceuticals?
Key investors in Ernest Pharmaceuticals include National Cancer Institute, The Termeer Institute, Massachusetts Life Sciences Center, National Institutes of Health (NIH), Lever.
Will Ernest Pharmaceuticals IPO soon?
No public IPO plans have been announced for Ernest Pharmaceuticals.
How can I track Ernest Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Ernest Pharmaceuticals's shares on secondary markets.